Titan Spine

About:

Titan Spine designs and manufactures interbody fusion devices for use in the cervical and lumbar spine.

Website: http://www.titanspine.com/

Twitter/X: Titan_Spine

Top Investors: Southlake Equity Group

Description:

Titan Spine designs and manufactures interbody fusion devices for use in the cervical and lumbar spine. It offers Endoskeleton TL, a lateral fusion device for the lumbar spine; Endoskeleton TAS, an anterior lumbar interbody fusion (ALIF) interbody device with screws; Endoskeleton TA, a device for ALIF procedures; Endoskeleton TT, a device for transforaminal lumbar interbody fusion (TLIF) procedures; Endoskeleton TO, a device for posterior lumbar interbody fusion (PLIF) and oblique procedures; Endoskeleton TCS, a cervical interbody device with screws for anterior discectomy and fusion (ACDF); and Endoskeleton TC, a device for anterior discectomy and fusion (ACDF) procedures. Titan Spine serves patients in the United States and Europe through its sales force and a network of independent distributors. It has a strategic partnership with MBA. Kevin Gemas and Peter Ullrich founded Titan Spine in 2006. It has its headquarters in Mequon in Wisconsin with a location in Laichingen in Germany.

Total Funding Amount:

$50.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mequon, Wisconsin, United States

Founded Date:

2006-01-01

Contact Email:

tsinfo(AT)titanspine.com

Founders:

Kevin Gemas, Peter Ullrich

Number of Employees:

101-250

Last Funding Date:

2018-11-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai